Arbutus Biopharma Corporation (ABUS) dipped -8.71% or -0.37 to $3.88. It is about 225761 shares traded, which is 111.32% compare to the average total volume 202800. The market cap of ABUS is $215.25 million. The year to date change is -30.72%. The 52 week price range is from $3.66 to $12.6. Price of ABUS have changed -3.19% during last week. It have changed -4.71% over last month, -54.55% over last 3 months, -37.73% over last 6 months and -10.53% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ABUS is 4.64. It is 19.59% above current price. The 200-day Moving Averages for ABUS is 6.89. It is 77.58% above current price. The 52-week High is 12.6. It is 224.74% from the current price. The 52-week Low is 3.66. It is -5.67% from current price.
There are some statistics of ABUS. It is has market cap $215.25 million. The share outstanding is 55.48 million. The average volume is 202800. The percent of top 15 Institution holding is 52.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ABUS is -64.12%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ABUS is -34.25%.